Isobe N, Gourraud PA, Harbo HF, et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology. 2013;81(3):219-27. doi:10.1212/WNL.0b013e31829bfe2f
Patsopoulos NA, Barcellos LF, Hintzen RQ, et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet. 2013;9(11):e1003926. doi:10.1371/journal.pgen.1003926
Cui J, Taylor KE, Lee YC, et al. The influence of polygenic risk scores on heritability of anti-CCP level in RA. Genes Immun. 2014;15(2):107-14. doi:10.1038/gene.2013.68
Okada Y, Kim K, Han B, et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet. 2014;23(25):6916-26. doi:10.1093/hmg/ddu387
Dunstan SJ, Hue NT, Han B, et al. Variation at HLA-DRB1 is associated with resistance to enteric fever. Nat Genet. 2014;46(12):1333-6. doi:10.1038/ng.3143
Kim K, Bang SY, Lee HS, et al. The HLA-DRβ1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations. Nat Commun. 2014;5:5902. doi:10.1038/ncomms6902
Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015;47(2):172-9. doi:10.1038/ng.3176
Canhao H, Rodrigues AM, Santos MJ, et al. TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapy. Biomed Res Int. 2015;2015:490295. doi:10.1155/2015/490295
Viatte S, Plant D, Han B, et al. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA. 2015;313(16):1645-56. doi:10.1001/jama.2015.3435
Kim K, Jiang X, Cui J, et al. Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis. Arthritis Rheumatol. 2015;67(10):2611-23. doi:10.1002/art.39228